Sentante
PrivateLast Round
Grant
Jul 9, 2024
Total Funding Raised
$9.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sentante is a medical technology company that develops a fully robotic teleoperated system for endovascular interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sentante Comparables
Compare Sentante with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoflex Robotics | 92% | |
| Remedy Robotics | 90% | |
| XCath | 89% |
Sentante Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2024 | ||||
| Seed | Dec 21, 2023 | ||||
| Grant | Jun 16, 2021 |
Key People
Founding team and executive leadership
Sentante Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Practica Capital | Seed |
| European Regional Development Fund | Grant |
| European Innovation Council Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 122% MoM, reaching 1.2K.
- Aug 2, 2026
Grew 18% QoQ, from 33 to 39 employees.
Recent news
Latest coverage and updates
- integrates_withAug 25, 2026
Sentante integrates with NVIDIA Corporation.
- launchesJul 15, 2026
Sentante launched precision-controlled digital indeflator - dubbed 'Inflante' on Jul 15th '26.
- receives_awardJun 29, 2026
Sentante received award Groundbreaking Technology at Surgical Robotics Technology (SRT) Industry Awards 2026 on Jun 29th '26.
Sentante Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sentante's valuation, stock price, and market status.
Is Sentante a public or private company?
Sentante is a private company.
What is the current stock price of Sentante?
Sentante is a private company with no public stock price. No recent secondary market data is available.
How much is Sentante worth (valuation)?
Valuation information for Sentante is not publicly available.
Can I buy Sentante stock?
Sentante shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sentante's last funding round?
Sentante's most recent funding round was Grant on July 9, 2024.
Who are the main investors in Sentante?
Key investors in Sentante include Practica Capital.
Will Sentante IPO soon?
No public IPO plans have been announced for Sentante.
How can I track Sentante secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sentante's secondary market activity and sign up for updates.